Literature DB >> 583024

Maturity of fetal lungs tested by production of stable microbubbles in amniotic fluid.

R E Pattle, C C Kratzing, C E Parkinson, L Graves, R D Robertson, G J Robards, J O Currie, J H Parsons, P D Sutherland.   

Abstract

Lung surfactant in amniotic fluid, and hence the maturity of the fetal lungs, can be assessed by observation of stable microbubbles (less than 15 micron diameter). Bubbles are formed by agitation with a Pasteur pipette and examined in hanging drops under the 10 x power of a microscope. Either after a count of bubbles, or after a general survey of hanging drops, the fluid is given a stable microbubble rating. A 'strong' rating indicates that the idiopathic respiratory distress syndrome will not occur after delivery, and that the lecithin/sphingomyelin ratio will indicate maturity. Complete absence of stable microbubbles suggests a high risk of respiratory trouble for the newborn infant, as does a weak or lower rating in the 30 to 37 week gestational age group. The test takes 5 to 10 minutes to perform, is cheap and easy, is not affected by blood, but may be affected by meconium. If a 'strong' rating is found, measurement of the L/S ratio can safely be omitted.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583024     DOI: 10.1111/j.1471-0528.1979.tb10823.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  8 in total

1.  Evaluation of surfactant function at birth determined by the stable microbubble test in term and near term infants with respiratory distress.

Authors:  Humberto H Fiori; Roseli Henn; Matteo Baldisserotto; Igor G O Bica; Renato M Fiori
Journal:  Eur J Pediatr       Date:  2004-06-08       Impact factor: 3.183

2.  Stable microbubble test for predicting the risk of respiratory distress syndrome: II. Prospective evaluation of the test on amniotic fluid and gastric aspirate.

Authors:  S Chida; T Fujiwara; M Konishi; H Takahashi; M Sasaki
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

3.  Stable microbubble test for predicting the risk of respiratory distress syndrome: I. Comparisons with other predictors of fetal lung maturity in amniotic fluid.

Authors:  S Chida; T Fujiwara
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

4.  Chorioamnionitis and serum IgM in Wilson-Mikity syndrome.

Authors:  M Fujimura; T Takeuchi; H Kitajima; M Nakayama
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

5.  Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease.

Authors:  T Ogihara; K Hirano; T Morinobu; H S Kim; M Hiroi; H Ogihara; H Tamai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

6.  Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA.

Authors:  M Konishi; T Fujiwara; T Naito; Y Takeuchi; Y Ogawa; K Inukai; M Fujimura; H Nakamura; T Hashimoto
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

Review 7.  Techniques to evaluate surfactant activity for a personalized therapy of RDS neonates.

Authors:  Chiara Autilio
Journal:  Biomed J       Date:  2021-11-07       Impact factor: 4.910

8.  Exogenous pulmonary surfactant as a vehicle for antimicrobials: assessment of surfactant-antibacterial interactions in vitro.

Authors:  Alexei Birkun
Journal:  Scientifica (Cairo)       Date:  2014-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.